Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles-Reference-Cited by-同舟云学术

Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles

Published:2020-06 Issue: Volume:14 Page:252-261
ISSN:2352-3204
Container-title:Regenerative Therapy
language:en
Short-container-title:Regenerative Therapy

Author:

Watanabe Takayuki,Tsuchiya Atsunori^ORCID,Takeuchi Suguru,Nojiri Shunsuke,Yoshida Tomoaki^ORCID,Ogawa Masahiro,Itoh Michiko,Takamura Masaaki,Suganami Takayoshi,Ogawa Yoshihiro,Terai Shuji

Funder

Ministry of Education, Culture, Sports, Science, and Technology

Publisher

Elsevier BV

Subject

Developmental Biology,Biomedical Engineering,Biomaterials

Reference25 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome;Yki-Jarvinen;Lancet Diabetes Endocrinol,2014

3. Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis;Itoh;Am J Pathol,2011

4. Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans;Itoh;PloS One,2013

5. Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis;Komiya;Sci Rep,2017

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ex-vivo expanded CD34+ cell transplantation alleviates fibrotic liver injury via innate immune modulation in metabolic dysfunction-associated steatohepatitis mice;Cytotherapy;2024-08

2. Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease;World Journal of Stem Cells;2024-07-26

3. Role and therapeutic perspectives of extracellular vesicles derived from liver and adipose tissue in metabolic dysfunction-associated steatotic liver disease;Artificial Cells, Nanomedicine, and Biotechnology;2024-06-04

4. Applications of emerging extracellular vesicles technologies in the treatment of inflammatory diseases;Frontiers in Immunology;2024-03-13

5. The role of extracellular vesicles in non-alcoholic steatohepatitis: Emerging mechanisms, potential therapeutics and biomarkers;Journal of Advanced Research;2024-03